Sen. Michael Bennett (D-CO) withdrew from Thursday's user fee markup his revised bill that aims to promote further research on pediatric cancer treatments, telling the Senate health committee that “we’re not in a place today to adopt the amendment.” A source close to the negotiations told Inside Health Policy that some provisions in the bill were included in the user fee manager’s amendment, and the rest of the provisions and recommendations from FDA are still being looked at. Bennet...